| Authors: |
Kelly LM; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Ling F; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Duchmann M; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Latour E; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Arang N; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Pasquer H; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Ho Nhat D; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Charles J; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Ang HX; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Namor F; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Culeux C; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Lombard B; Curie Institute, Mass Spectrometry and Proteomics Facility, PSL Research University, Paris, France., Loew D; Curie Institute, Mass Spectrometry and Proteomics Facility, PSL Research University, Paris, France., Swaney DL; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Gladstone Institutes, San Francisco, California, USA., Krogan NJ; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; Gladstone Institutes, San Francisco, California, USA., Brunel L; IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France., Carretero É; IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France., Verdié P; IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France., Amblard M; IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France., Fodil S; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Huynh T; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Sebert M; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Adès L; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Raffoux E; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Fenouille N; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Itzykson R; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.; Department of Hematology and Immunology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Lobry C; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Benajiba L; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France.; Clinical Investigation Center, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France., Forget A; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Martin AR; IBMM, University of Montpellier, CNRS, ENSCM, Montpellier, France. anthony.martin@umontpellier.fr., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu., Puissant A; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France. alexandre.puissant@inserm.fr. |
